The first target sequence for miRNA assay development was derived from searches in the regions of TMPRSS2 and Ets family member chromosomal breakpoints (21q21.2–21.3) because this region has been associated with aggressive forms of prostate cancer [23,24]. Here, TMPRSS2 is linked to Familial prostate cancer.